FRANKLIN LAKES, N.J. , Nov. 15, 2019 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX) announced today that it has been notified of an unsolicited mini-tender offer by TRC Capital Investment Corporation ("TRC") to purchase up to 500,000 shares of BDX common stock at a price of

FRANKLIN LAKES, N.J. , Nov. 14, 2019 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Jefferies 2019 London Healthcare Conference on Thursday, November 21, 2019 , at 6:20 a.m. ET .

FRANKLIN LAKES, N.J. , Nov. 12, 2019 /PRNewswire/ --   BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug Administration ( FDA ) for an expanded version

- As reported, full fiscal year revenues of $17.290 billion increased 8.2 percent. - On a comparable, currency-neutral basis, revenues increased 5.1 percent for the full fiscal year. - As reported, full fiscal year diluted earnings per share of $3.89 increased 548.3 percent.

  FRANKLIN LAKES, N.J. , Oct. 3, 2019 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2019 earnings conference call on Tuesday, November 5, 2019 , at 8:00 a.m. (ET) .

Independent analysis of LUTONIX® 035 Drug Coated Balloon patient-level data showed no statistically significant mortality increase     FRANKLIN LAKES, N.J. , Sept. 28, 2019 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced